Ocular Monkeypox — United States, July–September 2022

CDC Monkeypox Clinical Escalations Team

Research output: Contribution to journalArticlepeer-review

52 Scopus citations
Original languageEnglish (US)
Pages (from-to)1343-1347
Number of pages5
JournalMorbidity and Mortality Weekly Report
Volume71
Issue number42
DOIs
StatePublished - Oct 21 2022

Bibliographical note

Funding Information:
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. James Chodosh is a consultant to the Food and Drug Administration, where he chairs an advisory committee for new ophthalmic medications. He also receives grant support from the National Institutes of Health (NIH) to study adenovirus keratitis. Caitlin M. Dugdale reports institutional support from the National Institute for Child Health and Human Development, NIH; Harvard University Center for AIDS Research; the Massachusetts General Hospital Executive Committee on Research; the International AIDS Vaccine Initiative; and the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Network, NIH. Aaron R. Kaufman reports support by a Heed Fellowship awarded by the Heed Ophthalmic Foundation. Roberto Pineda II reports royalties from Elsevier and consulting fees from Sanofi-Genzyme. No other potential conflicts of interest were disclosed.

Cite this